{"id":"W4399702155","doi":"10.1093/ecco-jcc/jjae079","title":"Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials","year":2024,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; McGill University Health Centre","funders":"Samsung; Genentech; Norgine; Medac; Sun Pharma; Nordic Pharma Group; Ono Pharmaceutical; Celltrion; Boston Pharmaceuticals; Mylan; Teva Pharmaceutical Industries; Gilead Sciences; Sanofi; Roivant Sciences; Celgene; Biogen; GlaxoSmithKline; Amgen; Dr. Falk Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Placebo; Internal medicine; Janus kinase inhibitor; Ulcerative colitis; Clinical trial; Clinical endpoint; Subgroup analysis; Gastroenterology; Janus kinase; Receptor; Confidence interval; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005497632,0.0006051257,0.002084419,0.0002884277,0.000256522,0.000981841,0.0002840463,0.0006658784,0.002395051],"category_scores_gemma":[0.004072071,0.0002940984,0.003600909,0.0003250042,0.0002928176,0.0005691487,0.0003936015,0.001077347,0.0002234136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000257914,"about_ca_system_score_gemma":0.0004342094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002565868,"about_ca_topic_score_gemma":0.001479528,"domain_scores_codex":[0.9968971,0.002064825,0.0003762237,0.0002849401,0.0001899512,0.0001869535],"domain_scores_gemma":[0.9977537,0.001088203,0.0005831395,0.0002100851,0.0001210672,0.000243766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8943762,0.0008788878,0.02157261,0.001460544,0.01618329,0.0001377168,0.0001284275,0.0009303826,0.00550493,0.0001408187,0.0009822887,0.05770402],"study_design_scores_gemma":[0.4852859,0.2216143,0.2216935,0.0008002515,0.05158842,0.0008323445,0.0002913128,0.002908346,0.005635157,0.001081927,0.008119955,0.0001485765],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.983257,0.01279033,0.0003490599,0.00028164,0.00008763768,0.0003977681,0.0005968491,0.00002294286,0.002216697],"genre_scores_gemma":[0.9966514,0.001464755,0.0002548176,0.0002407657,0.0001106416,0.0002949377,0.0005012309,0.000007379334,0.0004740738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005497632,"threshold_uncertainty_score":0.02907461,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0243559381734942,"score_gpt":0.3175080892498095,"score_spread":0.2931521510763153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}